Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer

Cancer Immunology, Immunotherapy

Volumn 52, Issue 10, 2003, Pages 599-607

  Tsukishiro, Takashi ^a,b   Donnenberg, Albert D ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CD8+ T cells; CD8+CD28 subset; Head and neck cancer

Indexed keywords

ANNEXIN; CD28 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANZYME B;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURGERY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HEAD CANCER; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MIXED LYMPHOCYTE CULTURE; NECK CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; TUMOR GROWTH; TURNOVER TIME;

ADULT; AGED; ANNEXIN A5; ANTIGENS, CD28; ANTIGENS, CD45; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 0142010674     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0395-6     Document Type: Article

References (38)

1. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G (1993) The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: the role of apoptosis in T cell memory. J Exp Med 178:427
2. - T lymphocytes: antigenic and functional properties, J Immunol 150:1147
3. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
4. - T cells. AIDS 8:431
5. Boucher N, Dufeu-Duchesne T, Vicaut E, Farge D, Effros RB, Schachter F (1998) CD28 expression in T cell aging and human longevity. Exp Gerontol 33:267
6. Bryder DB, Ramsfjell V, Dybedal I, Theilgaard-Monch K, Hogerkorp C-M, Adolfsson J, Borge OJ, Jacobson SEW (2001) Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med 194:941
7. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ (2001) Down-regulation of CD28 expression by TNF-α. J Immunol 167:3231
8. Cardi G, Heaney JA, Schned AR, Ernstoff MS (1998) Expression of Fas (APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma. Cancer Res 58:2078
9. Daniel PT, Kroidl A, Cayeux S, Bargou R, Blankenstein T, Dorken B (1997) Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J Immunol 159:3808
10. + peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 7:947S
11. Eck SC, Turka LA (1999) Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells. Can Immunol Immunother 48:336
12. Gastman BR, Atarashi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL (1999) Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 59:5356-5364
13. + cells. J Exp Med 186:1407
14. Heo DS, Snyderman CH, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49:5167
15. Hoffmann TK, Dworacki G, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8:2553
16. short and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur J Immunol 30:2765
17. Lang S, Atarashi Y, Nishioka Y, Stanson J, Meidenbauer N, Whiteside TL (2000) B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. Cellular Immunol 201:132
18. Lezzi G, Karjalainen K, Lanzavecchia A (1998) The duration of antigenic stimulation determines the fate of naïve and effector cells. Immunity 8:89
19. McDonagh M, Bell EB (1995) The survival and turnover of mature and immature CD8 T cells. Immunol 84:514
20. - T lymphocytes is dominated by expanded clones that persist over time. Clin Exp Immunol 117:298
21. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 190:705
22. Prince HE, York J, Jensen ER (1992) Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression. Cellular Immunol 145:254
23. Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL (1998) Lymphocyte apoptosis induced by Fas Ligand-expressing ovarian carcinoma cells. J Clin Invest 101:2579
24. Raitakari M, Brown RD, Sze D, Yuen E, Barrow L, Nelson M, Pope B, Esdale W, Gibson J, Joshua DE (2000) T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Br J Haematol 110:203
25. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL (2002) Signaling abnormalities, apoptosis and reduced proliferation of circulating and tumor0infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8:3137
26. Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL (1999) Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 5:1263
27. + T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 6:1351
28. Seliger B, Cabrera T, Garrido F, Ferrone S (2002) HLA class I antigen abnormalities and immune escape by malignant cells. Semin Cancer Biol 12:3
29. Thor Straten P, Becker JC, Guldberg P, Zeuthen J (1999) In situ T cells in melanoma. Cancer Immunol Immunother 34:386-395
30. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J (2000) Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-regulated CD3ζ and CD28, key signaling molecules for T-cell activation. J Virol 74:7320
31. Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, His ED, Bander NH, Novick AC, Finke JH (1999) Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res 5:1219
32. - T ells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis. Leukemia 12:1573
33. Verhoven B, Schlegel RA, Williamson P (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182:1597
34. Walker LS, McLeod JD, Boulougouris G, Patel YI, Hall ND, Sansom DM (1998) Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunol 94:41
35. Walsh PT, O'Connor R (2000) The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol 30:1010
36. Whiteside TL, Bryant J, Day R, Herberman RB (1990) Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J Clin Lab Anal 4:102
37. Whiteside TL, Rabinowich H (1998) The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol and Immunother 46:175-184
38. Whiteside TL (2002) Tumor-induced death of immune cells: its mechanisms and consequences. Semin Cancer Biol 12:43